Indication
Lymphoproliferative disorder
1 clinical trial
1 product
Clinical trial
Administration of Rapidly Generated EBV-Specific Cytotoxic T-Lymphocytes To Patients With EBV-Positive LymphomaStatus: Recruiting, Estimated PCD: 2024-12-01
Product
EBV-specific T cells